NEW YORK (GenomeWeb News) – Agilent Technologies reported after the close of the market on Monday that fiscal second-quarter revenues rose 3 percent year over year while revenues for its Life Sciences segment increased 1 percent.

Total revenues for the three months ended April 30 increased to $1.73 billion from $1.68 billion a year ago, beating Wall Street estimates of $1.71 billion. Total orders increased 8 percent to $1.84 billion during the quarter from $1.70 billion a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: transcript patterns in drug-resistant cancer cells, function of high-altitude adaption gene, and more.

Monitoring gene expression changes could help sniff out athletes using performance-enhancing drugs, New Scientist says.

The University of Southern California lodges a cross-complaint in its legal dispute with the University of California, San Diego, over a large Alzheimer's disease project.

A National Science Foundation-funded project aims to give researchers access to a network many times faster than the Internet.